Odonate Therapeutics, Inc. Contracts & Agreements
16 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (3)
- Intellectual Property (1)
- Uncategorized (3)
- Description of Registered Securities (Filed With SEC on February 23, 2021)
- Odonate Therapeutics, Inc. Open Market Sale Agreement (Filed With SEC on February 23, 2021)
- Odonate Therapeutics, Inc. Common Stock Underwriting Agreement (Filed With SEC on September 1, 2020)
- Description of Registered Securities (Filed With SEC on February 20, 2020)
- Odonate Therapeutics, Inc. Common Stock Underwriting Agreement (Filed With SEC on June 28, 2019)
- Limited Liability Company Operating Agreement of Odonate Holdings, LLC (Filed With SEC on February 14, 2018)
- Odonate Therapeutics, Inc. 2017 Stock Option Plan (Filed With SEC on February 14, 2018)
- Form of Stock Option Award (Filed With SEC on February 14, 2018)
- Odonate Therapeutics, Inc. 2017 Employee Stock Purchase Plan (Filed With SEC on February 14, 2018)
- Form of Underwriting Agreement (Filed With SEC on November 27, 2017)
- Limited Liability Company Operating Agreement of Odonate Holdings, LLC (Filed With SEC on November 27, 2017)
- 2017 Stock Option Plan (Filed With SEC on November 27, 2017)
- Form of Stock Option Award (Filed With SEC on November 27, 2017)
- 2017 Employee Stock Purchase Plan (Filed With SEC on November 27, 2017)
- Form of Indemnification Agreement to be entered into between Odonate Therapeutics, Inc. and each of its directors and executive officers (Filed With SEC on November 27, 2017)
- License Agreement, dated as of June 3, 2013, with Daiichi Sankyo Company, Limited (Filed With SEC on November 13, 2017)
